ALTG vs MAMK

The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 2/9, indicating severe operational and profitability deterioration. Despite a bullish analyst recommendation and a high dividend yield, the company is deeply unprofitable (ROE: -160.65%, Profit Margin: -4.34%), leveraged excessively (Debt/Equity: 420.97), and has consistently missed earnings estimates by wide margins. Revenue is declining, cash flow metrics are unavailable, and the Price/Book ratio of 71.44 suggests extreme overvaluation relative to book value. While the stock has rallied 36.8% in the last month, long-term performance remains deeply negative with a 5Y change of -32.2%, raising concerns of speculative momentum rather than fundamental recovery.

MAMK exhibits a dangerous decoupling between its market price and fundamental value, evidenced by a Piotroski F-Score of 5/9 (Stable) but a Graham Number of only $1.00 against a current price of $13.16. While revenue growth is impressive at 43.70%, the company is barely profitable with a profit margin of 0.01% and a negative operating margin. The extreme P/E ratio of 219.33 and Price/Book of 17.81 suggest a speculative bubble rather than value creation. Despite a healthy balance sheet (low debt, high current ratio), the intrinsic value of $0.42 indicates the stock is severely overvalued.